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Abstract 
The development of long-lasting zirconia-based ceramics for implants, which are not prone to 
hydrothermal aging, has not been satisfactorily solved. Therefore, this study was conceived as 
an overall evaluation screening of novel ceria-stabilized zirconia-alumina-aluminate 
composite ceramic (ZA8Sr8-Ce11) with different surface topographies for use in clinical 
applications. Ceria-stabilized zirconia was chosen as the matrix for the composite material, 
due to its lower susceptibility to aging than yttria-stabilized zirconia (3Y-TZP). This 
assessment was carried out on three preclinical investigation levels, indicating an overall 
biocompatibility of ceria-stabilized zirconia-based ceramics both in vitro and in vivo. Long 
term attachment and mineralized extracellular matrix (ECM) deposition of primary 
osteoblasts was most distinct on porous ZA8Sr8-Ce11p surfaces, while ECM attachment on 
3Y-TZP and ZA8Sr8-Ce11 with compact surface texture was poor. In this regard, the animal 
study confirmed the porous ZA8Sr8-Ce11p to be the most favorable material, showing highest 
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bone-to-implant contact values and implant stability post implantation in comparison with 
control groups. Moreover, the microbiological evaluation revealed no favoritism of biofilm 
formation on the porous ZA8Sr8-Ce11p when compared to a smooth control surface. Hence, 
together with the in vitro in vivo assessment analogy, the promising clinical potential of this 
novel ZA8Sr8-Ce11 as an implant material was demonstrated. 
 
1. Introduction 
The development process of a novel biomaterial is multileveled and requires comprehensive 
evaluation and safety assessments of the material’s effects on target tissues and their cells to 
ensure successful clinical use and maximum patient benefit.  
In implant dentistry, zirconia-based oral implants became of interest, not only due to their 
excellent mechanical properties, but also due to their superior aesthetics and biocompatibility 
characteristics in vitro[1] and in vivo.[1e, 2] In particular, the high strength, greater than 
1200 MPa,[3] exhibited by yttria-stabilized zirconia ceramics (Y-TZP) allows them to resist 
intermittent forces which arise during mastication.[3-4] Before its application in dentistry, 
zirconia was used as a material for femoral head balls used in hip replacements. In 2001/2002, 
numerous femoral head failures occurred in certain batches processed with a new type of 
furnaces.[5] The evaluation of the failures lead to the conclusion that the low stability of those 
femoral heads was due to increased hydrothermal aging or Low Temperature Degradation 
(LTD) associated with a change in the process. The tetragonal (t) to monoclinic (m) 
transformation specific for metastabilized zirconia is responsible for the LTD-phenomenon. 
The underlying mechanism of LTD is that the surrounding humidity reacts with oxygen on 
the zirconia surface leading to the production of OH--ions. These ions penetrate into the 
interior by grain boundary diffusion and fill up oxygen vacancies. In the end this leads to t-m 
transformation on the surface, which results in material uplift and crack initiation. Humidity 
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now has the possibility to penetrate deeper into the material, resulting in a sustained effect 
regarding the process of t-m transformation. Due to this process, the material loses its stability 
and in the most severe cases, this may lead to implant fracture.[5-6] The challenge now is to 
produce zirconia ceramics which are not prone to the hydrothermal aging, but are able to 
transform from the tetragonal into the monoclinic phase for enhancing transformation 
toughening. These zirconia ceramics should also have the same biological properties as the Y-
TZP ceramics.  
Within the LONGLIFE European project (www.longlife-project.eu), we designed and 
developed innovative zirconia-based composites, in which equiaxial α-Al2O3 and elongated 
SrAl12O19 phases are dispersed in a ceria-stabilized zirconia matrix. For a detail description of 
this ceria-stabilized zirconia-alumina-aluminate composite, the reader may refer to two recent 
papers on the synthesis of the composite material[7] and on its specific features in terms of 
mechanical properties.[8] In brief, the composite reaches an unprecedent degree of 
microstructure refinement thanks to a novel, patented[9] nano-powder engineering route, in 
which commercial zirconia powders were coated by inorganic precursors of the second phases, 
which crystallize on the zirconia particles surface under proper thermal treatment.[7] Thanks to 
this powder-coating strategy and a fine tuning of the amount of ceria inside the zirconia 
matrix, we were thus able to process ultra-fine composite structures after sintering, which 
exhibited a combination of mechanical properties never obtained so far.[7] The material 
exhibits high biaxial bending strength (up to 1.1 GPa) and fracture toughness (>10 MPa√m). 
Moreover, in these composite ceramic, zirconia transformation precedes failure, leading to a 
significant degree of transformation-induced ductility and an exceptionally high Weibull 
modulus, in the range typically reported for metals. Being stabilized with cerium instead of 
yttrium, the material did not exhibit any sensitivity to LTD. The results thus demonstrated the 
high potential of using these new strong, tough and stable zirconia-based composites in 
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structural biomedical applications, for example in implant dentistry. In this application, a 
careful and thorough in vitro and in vivo investigation is necessary, with a specific attention 
on cell, tissue and microorganisms interactions with the implant material.  
With regard to the risk assessment in vitro, the vast majority of studies aiming at examining 
cell response to implant materials utilize cells of non-human origin, or cells that do not 
represent oral implant targets. Frequently used cells in these experimental studies include 
human osteosarcoma[10] and mouse myoblast cell lines,[11] human mesenchymal stem cells,[12] 
osteoblasts derived from rat bone marrow,[13] or primary rat osteoblasts. [14] Numerous 
investigations have demonstrated significant differences in cell reactions in response to 
different culture conditions, such as the use of hormones and growth factors, as well as 
biomaterial surface characteristics. These differences were most likely related to the cell 
source and phenotype responding to the given experimental conditions.[15]  
Therefore, the objective of this study was to examine the influence of this newly developed 
implant material on specific cell functions of implant-relevant target cells that is, primary 
human alveolar bone osteoblasts, and compare these results with respect to transferability, 
with a concomitant risk assessment in vivo using an established rat model followed by 
histological analyses and biomechanical stability tests.  
A further important point which has to be taken in account, is, that the maintenance of implant 
materials in the human body is primarily threatened by multibacterial colonization, namely 
biofilms able to colonize various material surfaces and induce persistent biofilm-related 
infections[16] such as periimplantitis.[17] The incidence of periimplant inflammation has 
recently increased and was reported to vary between 28 % and 56 %, particularly in patients 
with history of periodontitis.[18] Therefore, we included an examination of the interaction of 
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microorganisms and material surface in our assessment of this newly developed zirconia-
based ceria-stabilized oral implant material. 
 
2. Results and Discussion 
2.1. Surface characterization  
For the following material and biological evaluation methods, the materials have been 
grouped on the basis of their chemical composition and surface treatments as follows:  
(i) pre-sintered 3Y-TZP substrates coated with (a) 3Y-TZP, (b) the new composite ceramic 
ZA8Sr8-Ce11, (ii) sintered 3Y-TZP substrates coated with porous ZA8Sr8-Ce11 (referred to as 
ZA8Sr8-Ce11p; p = porous), (iii) sandblasted titanium (referred to as Ti)  
The comparison of the biological performance on the new ZA8Sr8-Ce11 ceramic with 
established 3Y-TZP within group (i) allowed us thereby evaluating the impact of the chemical 
properties of the new ceramic composite versus an established zirconia-based material, since 
both surfaces were generated using the same technique and therefore displaying similar 
topographical features. By comparing in vitro and in vivo data on chemically identical but 
structurally different ZA8Sr8-Ce11 surfaces, namely porous ZA8Sr8-Ce11p versus ZA8Sr8-
Ce11, we further obtained information on the direct influence of surface topography on cell 
functions and integration into bone tissue. The inclusion of a titanium control group which 
represents an already clinically applied “state-of-the-art” implant surface helped us to estimate 
the quality of the later clinical performance of the new ceramic composite.     
Since different surface treatments were applied to the zirconia materials, we firstly analyzed 
biomaterial surface topography by Scanning Electron Microscopy (SEM) and white light 
interferometry (IFM).The SEM analysis revealed that the surfaces of the different implant 
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groups can be clearly distinguished from each other with regard to surface structure (Figure 
1). The only exceptions were 3Y-TZP and ZA8Sr8-Ce11, which displayed a similar compact 
and grainy surface texture due to the comparable coating process. Disks for the in vitro 
evaluation and implants destined for the animal study were both made from bulk 3Y-TZP and 
afterwards coated in the pre-sintered state either with a colloidal suspension of 3Y-TZP or the 
zirconia-based composite ceramic ZA8Sr8-Ce11 respectively. When the coatings were applied 
on the pre-sintered substrate of 3Y-TZP, the homogeneous shrinkage of both, the substrate 
and the coating during sintering, allowed the coating to be densified and tightly linked to the 
substrate. A high magnification figure shows that the single particles of both coatings were 
well sintered leaving no pores between the particles (Figure 1, lower row). Both test surfaces 
were homogeneous and smooth, without sharp edges or extruding peaks or deep sharp valleys. 
By contrast, when the coating of the ZA8Sr8-Ce11p composite material was applied on a 
sintered substrate of 3Y-TZP, the sintering shrinkage of the coating during the densification 
was restricted due to the already fully dense substrate. This contributed to the formation of a 
porous surface with apparently high interconnectivity of the pores compared to the surfaces 
obtained when the coating was applied on pre-sintered substrates. The surface of the Ti 
control group was airborne particles abraded with BCP® (a mixture of hydroxyapatite (HA) 
and beta-tricalcium phosphate (β-TCP)) and passivated in acid. The resulting rough surface 
displayed a flaky appearance with sharp edges and multimorphological depressions. The 
abrasive BCP-particles used obviously created the irregular impressions/valleys. The valleys’ 
extensions ranged from approximately 1 µm to more than 20 µm and created a non-
homogenous surface. Upon examining surface topography parameters of the implant surfaces 
to be used for in vitro testing, the main roughness parameters Sa and Sq indicate that the 
zirconia-based surfaces had comparable rough surface properties, ranging from Sa = 0.187 µm 
and Sq = 0.243 µm for 3Y-TZP to Sa = 0.228 µm and Sq = 0.293 µm for ZA8Sr8-Ce11p (Table 
1), whereas the Ti control group showed the highest roughness (Table 1, Sa = 1.46 µm and Sq 
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= 1.87 µm). In terms of the developed interfacial area ratio (Sdr in %), which describes surface 
enlargement as compared to a totally flat reference area, 3Y-TZP and ZA8Sr8-Ce11 had the 
lowest value with Sdr = 1.7 %, followed by the porous ZA8Sr8-Ce11p surface (Sdr = 3.18%) 
and Ti showing the highest surface enlargement (Sdr = 47.69%) (Table1). The higher surface 
enlargement of ZA8Sr8-Ce11p compared to the corresponding zirconia-based surfaces can be 
attributed to the high number of peaks per area (Sds) since a high density of peaks will 
contribute to surface enlargement. In summary, 3Y-TZP and ZA8Sr8-Ce11 demonstrated the 
smoothest surfaces, while the porous ZA8Sr8-Ce11p had a more pronounced surface roughness 
and Ti displayed the roughest surface properties.    
With respect to the implant surfaces destined for the animal study (hereafter referred to as 
Impl.3Y-TZP, Impl.ZA8Sr8-Ce11, Impl.ZA8Sr8-Ce11p and Impl.Ti) the IFM data indicated 
moderate changes in the topography parameters Sa, Sq and Sdr after transfer of the surface 
treatment process from 2D disks to 3D implants (Table 1). These modifications were 
characterized by a slight increase in all surface parameters of the zirconia-based materials, 
while simultaneously retaining the above-mentioned surface roughness trend within this 
group, namely similar surface properties for Impl.3Y-TZP (Sa = 0.32 µm; Sq = 0.39 µm; Sdr = 
3.29%) and Impl.ZA8Sr8-Ce11 (Sa = 0.34 µm; Sq = 0.42; Sdr = 3.00%), and higher surface 
roughness of the porous Impl.ZA8Sr8-Ce11p surface (Sa = 0.773 µm; Sq = 0.94 µm; Sdr = 
43.00%) (Table1). Therefore, Impl.3Y-TZP and Impl.ZA8Sr8-Ce11 could be classified as 
moderately rough surfaces and Impl.ZA8Sr8-Ce11p and Impl.Ti (Sa = 0.81 µm; Sq = 1.09 µm; 
Sdr = 17.69%) as rough surfaces.  
 
2.2. Cell culture evaluation 
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Previous work on cell responses to differently structured implant surfaces revealed serious 
impacts of the surface topography on cell functions including primary cell adhesion, 
morphology and proliferation.[19] Therefore, we first analyzed morphogenesis of osteoblasts 
on zirconia and titanium surfaces by scanning electron microscopy (SEM), fluorescence-
based actin cytoskeleton staining and quantitative morphometry after 1 and 7 days of culture 
(Figure 2).   
Osteoblast morphology on zirconia surfaces differed considerably from titanium surfaces at 
day 1, as revealed by SEM (Figure 2A, upper row) thereby depicting differences in the 
surface structure of the implant materials. In detail, no morphological differences could be 
detected between osteoblasts grown on grainy or porous surface structures, with the cells 
showing similar spreading and a flattened morphology for all of the zirconia surfaces 
examined. However, on titanium surfaces osteoblasts were less flattened compared to those 
grown on zirconia. They showed an elongated morphology with apparently limited contact at 
the surface grooves. A similar situation has been observed by fluorescence microscopy of 
phalloidin-labelled actin cytoskeleton in osteoblasts at day 1 on zirconia and titanium disks 
(Figure 2A, lower row). For zirconia-based surfaces actin fluorescence appeared at the lateral 
and apical cell borders, indicating actin stress fibers due to tension sites at the lateral and 
apical cell margins, coinciding with cell adhesion by potential focal contacts. Conversely, on 
the rougher titanium surface less actin bundling was observed, with strong actin fluorescence 
areas mainly located at the apical sites and throughout the cell soma, thereby suggesting that 
cell/surface contact was restricted to these areas. This is in agreement with observations from 
SEM, indicating that cell adhesion was apparently limited to the fractal surface protrusions of 
the titanium disks. Hence, the SEM analysis and actin cytoskeleton staining provide evidence 
for morphological differences of osteoblasts depending on surface topography of implant 
materials under study. To back up this suggestion, we performed fluorescence imaging 
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software-based quantitative morphometric cell measurement at days 1 and 7 (Figure 2B and 
Table S1) by determining the morphology index (the ratio between the long cell axis and 
short cell axis) describing the cell shape and the cell area, which in turn provides information 
about the degree of cell spreading. As already indicated in the qualitative microscopic 
analysis mentioned above, osteoblasts at day 1 discriminated between the different surface 
topographies, clearly showing the least elongated and spread morphology on the strongly 
structured titanium surface as represented by decreased morphology index and cell area as 
compared to cells on zirconia disks. This situation held true for osteoblasts at day 7 on 
titanium showing no changes in morphology index or cell area. Regarding morphogenesis on 
zirconia surfaces, osteoblasts showed significant changes in cell morphology during 
continuous culture, as characterized by decreasing morphology index and expanding cell area 
from day 1 to day 7, thereby indicating that cells changed to a less elongated and more spread 
morphology at later culture time points. Osteoblasts on 3Y-TZP therefore displayed the most 
spread morphology, while cell spreading on both ZA8Sr8-Ce11 surfaces appeared to a lesser 
extent. These cell morphological differences between zirconia and titanium surfaces are in 
agreement with previous observations showing a more spread osteoblast morphology on 
smoother surfaces when compared with rougher and strongly structured surfaces.[19,20] Of 
particular interest is the fact that intersurface comparison between 3Y- and ZA8Sr8-Ce11 
yielded different degrees of cell spreading irrespective of the surface topography, with a 
significantly less spread osteoblast morphology on both ZA8Sr8-Ce11 surfaces. This 
observation indicates that within the ceramic group cell spreading was modulated by the 
biomaterial chemistry, rather than by surface topography.  
SEM analysis and actin cytoskeleton staining provide evidence for morphological differences 
of osteoblasts depending on surface topography and chemistry. Therefore, we next examined 
putative surface-dependent effects on cell proliferation and mitochondrial activity. For this 
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purpose, we determined the DNA concentration in cell lysates and the reduction of the 
resazurin-based reporter dye alamarBlue (AB) in mitochondria by employing the same 
osteoblast cultures for the analyzed time points, namely 1, 3, 7 and 14 days. Since DNA 
quantity correlates directly with cell number, DNA concentration in our samples provided 
information about the amount of adherent cells on the different implant materials, and 
allowing conclusions to be made about cell proliferation on the biomaterials under study. 
Subsequent normalization of the metabolic AB reduction on DNA quantity also enabled the 
evaluation of the mitochondrial activity independent of the number of attached cells. In this 
way, any direct biomaterial-dependent impact on mitochondrial activity could be analyzed. 
As shown in Figure 1C, total DNA quantification generally revealed a continuous increase in 
cell numbers until day 14 on all of the implant materials under study. Comparing individual 
biomaterials, our data further showed that at early culture periods, as indicated by days 1 and 
3, cell number was elevated on titanium compared to the matched zirconia surfaces, while 
from day 7 on, DNA quantity was comparable, irrespective of the biomaterial and on all 
surfaces (see also Table S2). Since previous studies reported improved cell adhesion on 
rougher implant surfaces,[14,19] the increased DNA quantity on titanium at early culture time 
points in the present work may be due to improved initial cell adhesion compared to the 
moderately rough zirconia materials. Regarding AB reduction, however, osteoblasts on 
titanium displayed the lowest mitochondrial activity throughout the whole culture period, 
although they showed a similar trend as compared to 3Y-TZP and ZA8Sr8-Ce11 (Figure 1C 
and Table S2). In this context it was striking, that mitochondrial activity had slightly 
decreased on 3Y-TZP and Ti at day 3 and peaked at day 7 on 3Y-TZP, ZA8Sr8-Ce11 and Ti, 
before declining again at day 14. By contrast, mitochondrial AB reduction on porous ZA8Sr8-
Ce11p remained virtually unchanged until day 7 and decreased at day 14 to a degree to that 
seen with the previously mentioned surfaces. The decline in AB reduction at day 14 could be 
explained by a general decrease in mitochondrial activity caused by contact inhibition when 
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reaching high cell density on the substratum, as quiescent cells have lower requirements for 
protein and nucleotide synthesis than do proliferating cells.[21] This suggestion is substantiated 
by the previous work of Leontieva and co-workers, which demonstrated that contact 
inhibition in high density cell cultures is associated with deactivation of the mammalian target 
of rapamycin (mTOR) pathway.[22] In this context, mTOR acts as a major regulator of protein 
synthesis, mitochondrial energy and cell proliferation by stimulating mitochondrial functions 
and biogenesis. By contrast, the slight decline in mitochondrial activity at day 3 and the 
subsequent increase at day 7 on 3Y-TZP and Ti seemed rather to be the result of time-
dependent modulation in cell metabolism during the cell proliferation phase. Since there is to 
the best of our knowledge very little information to date on such time- and biomaterial-
dependent modulation of mitochondrial activity, especially in the case of Ti which yielded 
lowest AB reduction, the mechanism of this phenomenon remains to be established.  
A possible link between implant surface properties and mitochondrial activity may be 
signaling pathways such as the phosphatidylinositol 3-kinase (PI3K)/Akt pathway which 
mediates cell-matrix/substrate signaling via integrin receptors,[23] and has been suggested to 
be involved in the regulation of mitochondrial activity by translocation of activated Akt into 
the mitochondrial matrix.[24] Therefore, our previous experiments revealed that cell functions, 
including morphogenesis, early cell adhesion, proliferation and mitochondrial activity were 
modulated in both a time- and biomaterial- dependent manner. To test for putative effects on 
long-term cell attachment and osteogenic ECM mineralization by the different biomaterial 
surfaces under study, we performed long-term cell culture experiments with osteoblasts over a 
period of 28 days. During this time, cells were cultured in growth medium (GM) and 
osteogenic culture medium (OM) to support ECM mineralization. To visualize the attached 
cells under growth conditions, the cells were stained with Azur II dye, whereas calcium 
deposition into the ECM during the mineralization process was examined by ARS staining.  
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Figure 2D summarizes the results of the Azur II and ARS staining after 28 days of culture on 
zirconia- and titanium-based disks. As can be seen from the Azur II staining, all biomaterials 
were completely covered with a confluent cell monolayer, distinguishable by a blue coloring, 
and demonstrating excellent long-term cell attachment on all of the surfaces examined. 
Regarding calcium deposition, however, ARS staining yielded differential coverage of the 
biomaterials with mineralized ECM, thereby strongly suggesting dependence of ECM 
formation and/or attachment on surface topography. On smoother surfaces, namely 3Y-TZP 
and partly ZA8Sr8-Ce11, ECM coverage was virtually absent, with few exceptions on ZA8Sr8-
Ce11, whereas the rougher ZA8Sr8-Ce11p and Ti surfaces were completely covered with 
mineralized ECM, as indicated by the red stained areas. Additional staining of 3Y-TZP and 
ZA8Sr8-Ce11 disks with Azur II (data not shown) showed furthermore that the white 
unstained disk areas were not only free of mineralized ECM, but also lacking in attached cells. 
Since cell proliferation and attachment under growth conditions was detectable on all 
biomaterials, it can be speculated that the presence of such cell/ECM-free areas on the 
smoother surfaces may be due to a poor long-term cell and/or ECM adhesion under 
osteogenic culture conditions. The main difference between the mineralized and non-
mineralized osteoblast cultures was primarily in the deposition of calcium into the premature 
ECM, which most likely altered the mechanical properties of the matrix, making it more rigid 
than non-mineralized ECM and by this presumably more susceptible to mechanical stress-
induced detachment caused by slight agitation possibly occurring during the long-term culture. 
Our data therefore indicate that the formation and/or long-term adhesion strength of 
mineralized bone-like matrix on the biomaterials´ surface, which represents a prerequisite for 
successful hard tissue integration of implants,[25] was strongly affected by the surface 
topography and was obviously favored on biomaterials featuring more pronounced surface 
structures and increased area ratio (Sdr), namely ZA8Sr8-Ce11p and Ti, as compared to 3Y-
TZP and ZA8Sr8-Ce11 (see also Table 1 for detailed IFM values). These results clearly point 
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out the high impact of surface topography on mineralized ECM formation and/or attachment 
to biomaterials. Since due to the manufacturing process of the miniature implants for the 
animal study moderate changes in surface topography emerged which led to higher surface 
roughness of the zirconia-based surfaces as compared to the flat disks (Table 1), we also 
examined the formation and/or long-term adhesion of mineralized ECM on the 3D implant 
surfaces in vitro to check if cell behavior on the modified surfaces still correlated with 
previous results obtained from 2D disk cell cultures. When comparing 2D disk cell cultures 
(Figure 2D) with 3D mini-implant cultures (Figure 2E) it is evident, that higher implant 
surface roughness (reflected by higher Sa, Sq and Sdr values of the implants versus disks; 
Table 1) resulted in a considerable improvement in long-term cell and/or ECM adhesion on 
Impl.3Y-TZP and Impl.ZA8Sr8-Ce11, and to a lesser extent on Impl.ZA8Sr8-Ce11p, which 
already showed good cell and ECM adhesion in 2D culture. Regarding the Ti-based mini-
implants, surface treatment yielded lower surface roughness parameters than for Ti-based 
disks, but also surface properties more comparable to Impl.ZA8Sr8-Ce11p, as reflected by 
similar Sa and Sq values (Table 1). Accordingly, the cell and/or ECM adhesion on Impl.Ti was 
as good as that on Impl.ZA8Sr8-Ce11p (Figure 1E). Hence, the trend towards improved bone-
like ECM formation and/or adhesion with increasing surface roughness (Sa and Sq) and area 
ratio (Sdr) could be confirmed by the results from the 2D disk and 3D mini-implant long-term 
cultures. In summary, the results from the cell culture evaluation revealed that cell 
morphogenesis and metabolism, the latter reflected by mitochondrial activity, were 
considerably modulated in time- and biomaterial-dependent manner, demonstrating the 
weakest performance on Ti disks, which showed the roughest surface properties among tested 
biomaterials. Furthermore, long-term cell attachment differed distinctly between culture 
modes, namely basal growth and osteogenic differentiation conditions. While under growth 
conditions, osteoblasts formed confluent monolayers on all biomaterial surfaces, cell and 
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mineralized ECM attachment under osteogenic culture conditions were favored on rough and 
highly structured surfaces, namely ZA8Sr8-Ce11p and Ti. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
2.3. Animal study 
Our previous cell culture experiments showed that the topographical properties of the 
biomaterials under study significantly affected cell morphogenesis, mitochondrial activity and 
long-term attachment of mineralized bone-like ECM. At the tissue level, it is well known that 
the topographical and physicochemical surface properties of biomaterials play a crucial role 
for tissue integration during implant healing (reviewed in [26]). Therefore, we became 
interested in the in vivo performance of the novel ceria-stabilized zirconia composite ZA8Sr8-
Ce11 and the corresponding control materials, namely 3Y-TZP and Ti. To evaluate the 
implant healing into bone tissue after 14 and 28 days, we used the osseointegration research 
model established by Ogawa and co-workers (2000) which includes histomorphometrical 
analysis of the bone-to-implant-contact (BIC) and a biomechanical implant stability test, the 
so-called push-in test, in an established rat-animal model.[27] Within this study, 128 miniature 
implants were placed in the femurs of 64 rats for the histological analysis and biomechanical 
stability test, respectively.  
All animals recovered well from the surgical intervention. Healing after surgery was 
uneventful for all but 7 animals, where wound dehiscences of the skin occurred after one day 
in one leg each. All dehiscences were immediately resutured. No further problems were 
observed. After a 28 day healing period, all histological sections showed areas where 
mineralized bone and bone marrow spaces contacted the implant surface (Figure 3).  The 
histomorphometrical analysis revealed that the bone-to-implant contact after 14 days of 
healing in the cortical bone area was 28.1% for Impl.3Y-TZP, 24.9% for Impl.ZA8Sr8-Ce11, 
72.6% for Impl.ZA8Sr8-Ce11p and 10.7% for Impl.Ti (Table 2). After 28 days healing the 
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respective BIC values in the cortical bone were 55.3% for Impl.3Y-TZP, 43.3% for 
Impl.ZA8Sr8-Ce11os, 93.5% for Impl.ZA8Sr8-Ce11p and 16.9% for Impl.Ti. Accordingly, the 
porous Impl.ZA8Sr8-Ce11p surface showed the highest BIC values after 14 and 28 days, 
whereas the lowest values were seen with the Impl.Ti surface. For Impl.3Y-TZP and 
Impl.ZA8Sr8-Ce11 on the other hand, similar trends in BIC were observable at both time 
points, yielding significantly higher values than seen with Impl.Ti. 
Regarding implant healing in the spongious bone areas, BIC values at day 14 amounted to 
29.5% for Impl.3Y-TZP, 20.3% for Impl.ZA8Sr8-Ce11, 46.2% for Impl.ZA8Sr8-Ce11p and 
25.1% for Impl.Ti. After 28 days of healing, the values for the zirconia materials almost 
doubled whereas the BIC for Impl.Ti remained unchanged (Impl.3Y-TZP: 42%, Impl.ZA8Sr8-
Ce11: 47.8%, Impl.ZA8Sr8-Ce11p: 81.1%, Impl.Ti: 25.4%; Table 2). As already demonstrated 
for cortical bone healing, Impl.ZA8Sr8-Ce11p yielded here again the highest BIC values 
among all tested implant surfaces at both times of examination, therefore pointing to a 
preference bone formation along the implant surface by the porous surface topography. With 
respect to the BIC after 28 days for the porous zirconia surface (Impl.ZA8Sr8-Ce11p) used in 
this experiment, the values obtained are extraordinarily encouraging in comparison to other 
zirconia- and titanium-based implant surfaces examined to date,[28] and this also coincides 
with the results from the cell culture evaluation.    
The push-in test was performed at 14 and 28 days after healing and provides information on 
the degree of osseointegration by the breakpoint load at the implant-tissue interface. The 
average push-in values at 14 days were 10.2 N for Impl.3Y-TZP, 13.1 N for Impl.ZA8Sr8-
Ce11, 63 N for Impl.ZA8Sr8-Ce11p and 23.9 N for Impl.Ti. Here it is particularly noticeable 
that, of all the implant groups, the porous Impl.ZA8Sr8-Ce11p surface showed by far the 
highest push-in value, whereas the moderately rough implants Impl.3Y-TZP and 
Impl.ZA8Sr8-Ce11 had similar values, and the rougher Impl.Ti surface was in between. This 
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trend continued, in part, at day 28, thereby showing that the porous Impl.ZA8Sr8-Ce11p was 
again superior to the other implant surfaces. In detail, average push-in values at 28 days were 
35.4 N for Impl.3Y-TZP, 31.5 N for Impl.ZA8Sr8-Ce11, 65.5 N for Impl.ZA8Sr8-Ce11p and 
9.9 N for Impl.Ti (Table 3).  
The time-dependent comparison between the push-in force at days 14 and 28 further revealed 
that the force values increased only for the moderately rough implant surfaces Impl.3Y-TZP 
and Impl.3Y-TZP, whereas in the Impl.ZA8Sr8-Ce11p no significant change in push-in force 
was detectable. This indicates that the maximum stability of the porous Impl.ZA8Sr8-Ce11p 
was achieved much more rapidly after only 14 days of healing and to a much larger extend 
since the push-in force remained two times higher at 28 days. These findings together with the 
results from the histomorphometric analysis add to the body of evidence that porous implant 
surfaces/coatings may give rise to improved implant fixation, which is thought to be a result 
of bone ingrowth into the pores.[29] Regarding the Impl.Ti control surfaces, this test group 
showed the poorest performance with respect to BIC and implant stability (push-in force), 
even with a deterioration of the results over time.   
 
2.4. Microbiological evaluation  
The results from the cell-based in vitro evaluation and the animal study identified the novel 
porous ZA8Sr8-Ce11p surface to be the most promising dental implant biomaterial which 
promotes bone tissue integration. Another important issue in oral implant development is the 
avoidance of the formation of microbial biofilms, which can induce persistent biofilm-related 
infections such as peri-implantitis[17] and lead to inflammation driven bone resorption and 
finally even implant loss.[30] In this context, Albouy and co-workers demonstrated in a dog 
model that progression of experimentally induced peri-implantitis accompanied by plaque 
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formation as well as the outcome of its treatment, including biofilm removal, are influenced 
by the implant surface characteristics.[31] Against this background, we examined the initial 
adhesion and oral biofilm formation of bacteria derived from human saliva on the porous 
ZA8Sr8-Ce11p. Since it is well established that smooth surfaces with a Ra threshold of 0.2 µm 
impede unwanted biofilm formation and are therefore clinically established for the 
transcutaneous part of the implant, i.e. abutment,[32] we used a smooth ZA8Sr8-Ce11ab surface 
(ab = abutment; Ra = 0.2 µm, Sa = 0.002 µm, Sq = 0.007 µm, Sdr = 0.002%, Sds = 7057) as a 
control group to evaluate the microbiological performance of the porous ZA8Sr8-Ce11p 
surface.  
In order to analyze initial adhesion and biofilm formation on ZA8Sr8-Ce11p and ZA8Sr8-
Ce11ab we performed a quantitative analysis of adherent microorganisms on the test surfaces 
at 2 h and 3 days post adhesion by determining the colony forming units (CFUs) after 
desorption of the adherent microorganisms by ultrasonication.[33] The CFUs derived from 
bacteria adherent to ZA8Sr8-Ce11p and the ZA8Sr8-Ce11ab control are illustrated in Figure 4 
A, B. Despite the different surface topographies, the experimental zirconia surfaces ZA8Sr8-
Ce11p and ZA8Sr8-Ce11ab presented no significant differences in the bacterial growth of 
aerobic and anaerobic cultivable microorganisms after 2 h (initial adhesion) and 3 days 
(biofilm), respectively. Bacterial adhesion has been related to diverse surface parameters in 
the literature.[34] Among those parameters, average surface roughness has been the most 
studied[35] with regard to the antiadhesive behavior of numerous substrata.[36] As mentioned 
above, Ra values under 0.2 µm allow for the minimization of bacterial adhesion.[32] The more 
irregular and/rougher an implant surface is, the more bacteria colonize the pores or grooves at 
the surface attachment sites of an implant[33] to a maximum interface contact in order to avoid 
desorption and shear stress.[37] Interestingly, in this report surface roughness does not seem to 
correlate with initial bacterial adhesion or oral biofilm formation, as both surfaces presented 
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comparable colonization rates of adherent bacteria. Another important parameter influencing 
bacterial adhesion on biomaterials is the chemical surface composition which exerts its impact 
via physiochemical surface properties, namely material hydrophobicity and charge.[38] In this 
context, it has been shown that biomaterials with similar physicochemical properties resulted 
in similar protein binding patterns and, therefore, the composition of salivary pellicle 
proteins.[39] Since in the present study both test biomaterials had the same surface chemistry, 
it can be speculated that the comparable bacterial colonization rates seen among the tested 
zirconia surfaces correlate with their similar physicochemical features and the electrophoretic 
attributes of salivary proteins following saliva coating. Our results therefore imply that the 
chemical composition rather than the porous surface structure of the new zirconia composite 
determined bacterial adhesion and biofilm formation, when compared to the smooth control 
surface.  
Regarding the live/dead ratio of the attached bacteria to the porous ZA8Sr8-Ce11p and smooth 
ZA8Sr8-Ce11ab at 2 h and 3 days post adhesion, our data again found no significant difference 
in bacterial vitality between the two surfaces (Figure 4 C, D). The percentage of live and/or 
metabolically active bacteria (green fluorescence) was thereby higher in the initial stage after 
2 h (ZA8Sr8-Ce11p: 68.46 %; ZA8Sr8-Ce11ab: 62.66 %) than in the formed biofilm at day 3 
(ZA8Sr8-Ce11p: 11.15 %; ZA8Sr8-Ce11ab: 8.08 %). Such a decline in bacterial vitality and/or 
metabolism may be part of the physiological process during biofilm formation, as in vivo data 
from Bürger and co-workers revealed a high percentage of propidium iodide-positive bacteria 
in attached biofilms on titanium surfaces after only 12 h of intra-oral incubation.[40] Since to 
our best knowledge, there is little information on saliva-derived oral biofilm formation and 
vitality on implant surfaces in vitro, our data emphasize the need for further studies on oral 
biofilm development on implant materials.  
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In summary, our results reveal no favoritism of biofilm formation by the rough ZA8Sr8-Ce11p 
when compared to the smooth control surface and points to a good microbiological 
performance in vivo and its potential as prospective oral implant biomaterial. 
  
3. Conclusion 
Since preclinical evaluation of newly developed medical devices in vitro and in vivo is a 
major issue for device success, we focused in this study on a three-pronged strategy, including 
the analysis with (i) human osteoblasts on the cellular/molecular level, (ii) an animal study 
focusing on the level of bone to implant contact and (iii) a microbiological assessment in 
terms of initial bacterial adhesion and biofilm formation. Within the LONGLIFE European 
project, we designed and developed innovative zirconia-based composites, in which equiaxial 
α-Al2O3 and elongated SrAl12O19 phases are dispersed in a ceria-stabilized zirconia matrix and 
commercial zirconia powders are coated by inorganic precursors of the second phases, which 
crystallize on the zirconia particles surface under proper thermal treatment. Interestingly, the 
preclinical evaluation data revealed the ceria-stabilized zirconia-based implant material 
ZA8Sr8-Ce11 in conjunction with a porous surface topography to be a superior material for 
clinical application and substantiated the transferability of this study to the in vivo situation by 
using human and tissue-specific cells as an in vitro screening element.  
 
4. Experimental Section  
Preparation of the ceramic specimens and reference materials 
The synthesis of the new ceria-stabilized zirconia (Ce-TZP)-based composite has been 
described in details elsewhere.[7] This composite, referred to as ZA8Sr8-Ce11, has the 
following composition: 84 vol% ZrO2 - 8 vol% Al2O3 - 8 vol% SrAl12O19 , in which ZrO2 is 
stabilized by 11 mol% CeO2. To process the composite, a commercial 10mol% ceria–
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stabilized zirconia powder (Daiichi Kigenso Kagaku Kogio Co. LTD, Japan) was dispersed in 
distilled water and aluminium, strontium and ammonium cerium nitrates (Sigma-Aldrich) 
were added as precursors of α-alumina, strontium hexa-aluminate and to precisely tune the 
ceria content in the zirconia phase. The suspension was then spray-dried and thermally treated 
up to 1150°C to obtain a tri-phasic zirconia-alumina-strontium aluminate powder. A 3Y-TZP 
(Tosoh TZY-E, Japan) powder was used as a benchmark powder.  
In order to compare the ZA8Sr8-Ce11 with conventional 3Y-TZP (control group) while 
retaining the same topography a coating of both materials was applied by the same procedure 
on pre-sintered substrates of 3Y-TZP. The coatings were applied by spraying a colloidal 
suspension of the respective powders. The suspensions were prepared by ball milling of the 
ceramic powders using zirconia milling media, a poly acrylic acid as the dispersant and 
polyethylene glycol as the binder. As the coating was applied to pre-sintered substrates, the 
homogeneous shrinkage allowed both to become densified at the same time and tightly linked. 
The thickness of the dense coating was a few microns. For ZA8Sr8-Ce11 with a porous 
surface structure (ZA8Sr8-Ce11p), the Ce-TZP-based composite powder was applied on 
already sintered substrates of 3Y-TZP. When the coating was densified, shrinkage was only 
allowed in one direction due to the already dense substrate, contributing to an increased 
porosity of the coating. In addition to using 3Y-TZP as a reference ceramic material, titanium 
(Ti) was used as a “state-of-the-art” implant material in a further control group. The Ti-based 
specimens were made from titanium medical grade 23 (Ti-6Al-4V ELI) and have been 
sandblasted using air-borne particle abrasion with BCP® (a HA-TCP mix, Anthogyr, 
Sallanches, France). For the microbiological evaluation smooth ZA8Sr8-Ce11ab disks with 
surface properties representing an implant abutment area were prepared by leaving them with 
the as-pressed surface roughness of Ra = 0.2 µm. Biomaterial disks and implants destined for 
the biological evaluation were sterilized by low temperature hydrogen peroxide gas plasma 
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sterilization STERRAD 100/100S (Advanced Sterilization Products [A.S.P], Johnson & 
Johnson Medical, Irvine, CA). 
Surface characterization: The surface topography of the specimen was analyzed by Scanning 
Electron Microscopy (SEM, LEO435VP scanning electron microscope, Zeiss, Oberkochen, 
Germany) with the backscattered electron imaging mode and an accelerated voltage of 8.00 - 
12.00 kV and light interferometry (MicroXAM 100 HR; ADE Phase Shift Technology). 
Interferometry (IFM) measurements were made at three different areas on the specimen. To 
characterize the surface in height, spatial and surface enlargement four parameters were 
selected: the main roughness parameters Sa and Sq describe the arithmetic mean (Sa) and the 
root-mean-square (Sq) values of the absolute surface asperity departures, Sdr describes the 
surface enlargement compared to a totally flat reference area in % or as a ratio, and Sds 
measures the density of summits, i.e. number of peaks per area. Before parameter calculation, 
a digital (Gaussian) filter of 50 × 50 µm was applied in order to remove errors of form and 
waviness. The specimens used for SEM were sputter coated with gold-palladium for 60 s at 
60 mA (SCD050; Balzers, Liechtenstein). 
Culture of primary osteoblasts: Primary human osteoblasts were prepared from alveolar bone 
explants obtained from a 42-year old healthy male patient during an implant site preparation 
procedure. The collection of oral bone samples was approved by the Ethics Committee of the 
Albert-Ludwigs-University, Freiburg, Germany (vote Nr. 411/08_121010). Primary human 
alveolar bone osteoblasts were cultured in growth medium (GM) consisting of Dulbecco’s 
Modified Eagle’s Medium (PAA Laboratories, Coelbe, Germany) supplemented with 2% 
(w/v) glutamine (Gibco, Invitrogen, Karlsruhe, Germany), 10% (w/v) fetal calf serum 
(Biochrom AG, Berlin, Germany) and 0.2% (w/v) (50 µg/ml) kanamycin (Sigma-Aldrich, 
Taufkirchen, Germany). The cells were maintained in a humidified 37°C incubator with 5% 
CO2. All experiments were carried out with osteoblasts of passage 6. Extracellular matrix 
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mineralization was induced by incubating confluent cultures with osteogenic medium 
consisting of growth medium supplemented with 10 mM β-glycerophosphate disodium salt 
hydrate (Sigma-Aldrich), and 50 µg/ml sodium L-ascorbate (Sigma-Aldrich) for 28 days. For 
osteoblast culture on zirconia and titanium disks (15 mm diameter and 1 mm height) 0.5×104 
cells/ml were seeded per disk in a 24-well plate (0.26×104 / cm²).  
Evaluation of osteoblast morphogenesis: Cell morphology of osteoblasts on the biomaterials 
under study was examined by SEM (LEO435VP) and fluorescence-based phalloidin-labeling 
of actin. Therefore, the cells were fixed with 4% formaldehyde in PBS for 20 min at room 
temperature after 1 and 7 days of culture. For SEM analysis, specimens were then dehydrated 
in an ascending ethanol series (ranging from 30% to 100% ethanol, three times each for 20 
min at room temperature), critical point dried (CPD030 Critical Point Dryer; Bal-Tec AG, 
Balzers, Liechtenstein) and immediately sputter coated with gold-palladium for 60 s at 60 mA 
(SCD050; Balzers, Liechtenstein).   
For actin staining, the samples were treated with 2% (w/v) bovine serum albumin (Sigma-
Aldrich) and 0.2% TritonX-100 (Sigma-Aldrich) in PBS for 15 min at room temperature, and 
2% (w/v) bovine serum albumin in PBS for a further 15 min at room temperature. The 
phalloidin conjugate was diluted in PBS containing 0.5% (w/v) BSA and samples were 
incubated for 30 min at room temperature with the diluted conjugate. Nuclei were stained 
with Hoechst 33258 (Sigma-Aldrich) for 5 min at room temperature. Optical evaluation was 
performed with a Biozero BZ-8000 fluorescence microscope (KEYENCE, Neu-Isenburg, 
Germany). Quantitative morphometric analysis was performed with the microscope software 
BZ Analyzer II from KEYENCE. To achieve statistically valid data, we analyzed 2 to 4 disks 
per material group obtained from independent experiments and three areas per disk. This 
resulted in a total number of 205 - 598 measured cells per material group and time point. Cell 
morphology parameters were the morphology index, which is the ratio between the long cell 
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axis and short cell axis, describing the cell shape, and the cell area which in turn provides 
information about the extent of cell spreading. 
Evaluation of cell proliferation and metabolic activity: Metabolic activity of osteoblasts on 
zirconia- and titanium-based surfaces was assessed by the alamarBlue™ assay (AbD Serotec, 
Düsseldorf, Germany). The alamarBlue™ (AB) reagent comprises the redox-sensitive 
reporter dye resazurin, which is taken up by the cells and is reduced by mitochondrial 
respiration. The reduced product resorufin can be quantified in the supernatant by fluorometry. 
For this purpose culture medium was replaced after 1, 3, 7 and 14 days of culture with 
medium containing 10% (w/v) AB reagent. After incubation for 3 h at 37°C samples of the 
supernatant were analysed by measuring fluorescence (Tecan, Männedorf, Germany) 
according to the manufacturer’s instructions. The percentage of AB reduction in the samples 
was calculated using a 100% reduced AB control as a reference, which was produced 
according to the manufacturer’s protocol by autoclaving a sample containing culture medium 
with 10% (w/v) AB reagent for 15 min.  
Cell density was examined by determining the DNA content on the zirconia and titanium 
disks after 1, 3, 7 and 14 days of culture. For this, specimens previously used for the AB assay 
were washed once with PBS after AB sampling, and lysed by a freeze-thaw cycle at - 80°C in 
250 µl TE-buffer (10mM Tris-HCl, 1mM EDTA, pH7.5). DNA quantification was performed 
with the Quant-iT PicoGreen® assay (Invitrogen, Karlsruhe, Germany) according to the 
manufacturer’s instructions. 
Azur II and Alizarin Red S staining: Long-term cell attachment to zirconia and titanium disks 
was visualized by Azur II staining after 28 days. Azur II is a cationic dye which stains 
basophilic cell structures and was used for unspecific staining of adherent cell monolayers. 
Calcium deposition into the ECM during the mineralization process by osteoblasts was 
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analysed by Alizarin Red S (ARS) staining at day 28. For both staining methods cell layers 
attached to the disks were fixed in ice cold ethanol for 20 min, rinsed twice with distilled 
water and stained for 30 min with 0.1 % Azur II or 40 mM ARS (Sigma-Aldrich). 
Placements of miniature implants in the rat femur: The study protocol was approved by the 
Animal Research Committee of the University of Freiburg (35-9185.81/G-14/12). All animals 
were handled according to the policies and principles established by the German Animal 
Protection Law (“Deutsches Tierschutzgesetz”). Sixty-four 8-week-old male Sprague-Dawley 
rats were used in this investigation. The animals were initially anesthetized before the surgical 
intervention in a plastic container with an isoflurane-oxygen-mixture (3 Vol% isoflurane in 
100% oxygen with a flow of 4 l/min). After a deep anesthesia was reached, the animals were 
taken out of the inhalation chamber, a plastic mask was placed over the rat’s snout and the 
isoflurane concentration was reduced to 1.5 - 2 Vol% isoflurane in 100% oxygen and a flow 
of 0.5 - 1 l/min. The hind legs of the animals were disinfected with a povidone-iodine solution 
(Braunol, B. Braun Melsungen AG, Melsungen, Germany). Subsequently, legs were shaved 
and additionally disinfected. For access to the femur, an incision on the dorsal side of the 
femur was made through the skin and the muscles and a full-thickness flap was reflected to 
expose the distal femur. The periosteum was reflected using periosteal elevators. One 
cylindrical implant per femur was placed approximately 7 - 8 mm from the distal edge of the 
femur. The implant site was prepared by sequential drilling using a 0.7 mm round bur under 
sterile saline irrigation. With an endodontic file, the osteotomy was enlarged to 0.9 mm. The 
implants were then placed into the osteotomy and carefully pushed into place until the end of 
the implant was aligned with the femoral bone surface. After the correct implant position was 
achieved, the tissues were sutured in layers using resorbable sutures (Vicryl®, Ethicon GmbH, 
Norderstedt, Germany). At the end of the surgical intervention, the animals received a 
subcutaneous analgesic (buprenorphine, 0.1 mg/kg body weight, every 7 - 9 hours for two 
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days) and antibiotic (doxycycline, 100 mg/kg bodyweight, one application) treatment. The 
wounds of the animals were controlled on a daily basis and any occurring problems were 
registered. In the case of suture dehiscences, a resuturing was performed.  
Sixty-four implants in 32 rats were placed for histological analysis and 64 implants were 
placed in 32 rats for the biomechanical test using the push-in method. Thirty-two animals 
were sacrificed after a healing period of 14 days and 32 after a healing period of 28 days 
using a lethal dose of CO2 inhalation. The implants of the Impl.Ti and Impl.ZA8Sr8-Ce11p 
group were placed into the left and right femurs, respectively, of the same rats, whereas the 
groups Impl.3Y-TZP and Impl.ZA8Sr8-Ce11 were placed in the femurs of other rats. The 
distribution of the implants can be seen in Table S3. 
Histological procedure and histomorphometric analysis: The femurs of the animals were 
dissected free and the soft tissue was removed using scalpels and periosteal elevators. After 
rinsing the harvested implant-femur specimens of the histological groups (with 14 and 28 
days of healing) thoroughly with saline, they were immersed in 4% buffered formalin for 2 
weeks at 4°C. Then, the specimens were processed for histological evaluation according to 
the method of Donath and Breuner.[41] To remove the fixation solution, the specimens were 
rinsed in water. They were then dehydrated over a period of 18 days using an increasing 
alcohol gradient (50 - 100 % ethanol, 7 steps, Ethanol, Sigma Aldrich, Germany). The 
specimens were then embedded in Technovit 9100 (Heraeus Kulzer, Wehrheim, Germany). 
This is a polymerization system based on methylmetacrylate (MMA) which hardens at low 
temperature. The chemical process takes place under the exclusion of oxygen with the aid of a 
catalyst composed of peroxide and an amine component. Additional components such as 
PMMA-powder and a regulator allow controlled polymerization. First, the specimens were 
pre-infiltrated under permanent agitation at room temperature and then infiltrated at 4 °C. 
Then the samples that were positioned in containers and completely covered with 
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polymerization mixture were placed into a freezer and left to polymerize at -18 °C for two 
weeks. The samples were stored afterwards at 4 - 8 °C (refrigerator) for at least one hour 
before being allowed to come slowly to room temperature. When the samples were brought to 
ambient temperature, they were cut, grinded and glued (Technovit 7210 VLC, Heraeus Kulzer 
GmbH, Wehrheim, Germany) on object slides.  
Following the preparation process, the specimens were prepared with the use of the cutting-
grinding system (EXAKT-Apparatebau, Norderstedt, Germany) to get the final desired 
thickness. For the grinding process sandpapers of decreasing grits were used, beginning with 
800 grits and finishing with polishing grain size of 4000 grit. The final cut layer thickness was 
60 to 80 µm and was digitally verified (Mikrometer AW-10, EXAKT Apparatebau). Finally, 
the specimens obtained were stained with Azur II and Pararosaniline.[42]  
The sections through the implants were performed in a horizontal direction: one section was 
performed in the cortical bone layer and one in the spongious bone layer. Accordingly, two 
histological sections could be obtained from each implant. 
Histological observations and computer-assisted histomorphometric analysis were performed 
using a Zeiss Axioskop (Zeiss, Oberkochen, Germany) equipped with a video camera 
(ColorView III, Olympus, Münster, Germany) and the software program cell* (Olympus, 
Münster, Germany). The histomorphometric analysis comprised the evaluation of the fraction 
of the implant in contact to the cortical and spongious bone respectively using different 
magnifications (10x, 20x, 40x magnification). The healing periods as well as the implant 
materials/surfaces were unknown to the interpreter (blinded interpretation). 
Implant Push-in Test: After harvesting, the implant-femur specimens of groups C and D 
(Table S3) were immediately embedded into an autopolymerizing resin (Technovit 4071, 
Heraeus Kulzer, Wehrheim, Germany) in a custom-made metal mold. The implants were 
subsequently loaded axially in a universal testing machine (Zwick, Ulm, Germany) with a 10 
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kN load cell and a 0.8 mm diameter stainless steel pushing rod. The crosshead speed was 10 
mm/min. The applied load and the displacement of the implant were monitored.  
Culture of salivary bacteria: Paraffin-stimulated (CRT®, Ivoclar Vivadent AG, Schaan, 
Liechtenstein) human saliva (50 ml per proband) was obtained from six healthy volunteers 
who refrained from antibiotic use within the last 30 days prior to the beginning of the study. 
The study protocol was approved by the ethics committee of the Albert-Ludwigs-University 
of Freiburg (Nr. 91/15). The saliva was stored in -80 °C prior to use, while after the bacterial 
adhesion tests the adherent salivary bacteria were cultivated under both aerobic and anaerobic 
conditions on Columbia blood agar plates (CBA, Becton Dickinson, Heidelberg, Germany) at 
37 °C and 5 % CO2 and in anaerobic jars (Anaerocult A; Merck, Darmstadt, Germany) on 
yeast-cysteine blood agar (HCB) plates overnight, respectively.[43] The optical density of the 
salivary suspensions was assessed at 595 nm (Bio-Rad, Life Science Group, Hercules, CA, 
USA) against 0.9 % saline solution (NaCl) as a blank. The following assays were performed 
as multi-species experiments. 
Colony forming units (CFUs): Three samples of each material surface were placed into multi-
well plates (12-well plate; Greiner bio-one, Frickenhausen, Germany), one sample in each 
well. The samples were then stabilized by an A-silicone compound (Aquasil Ultra XLV; 
Dentsply, Milford, DE, USA) so that solely their upper surfaces remained uncovered by 
silicon, as described elsewhere.[44] Afterwards, 2 ml of the salivary suspension was injected 
onto each sample surface and was under constant swirling at 37 °C (5 % CO2) for 2 h and 3 
days, respectively. The silicone was then separated from the samples, which were washed 
twice with 5 ml 0.9 % NaCl solution and non-adherent bacteria were removed from the 
margins by sterile foam pellets (Voco GmbH, Cuxhaven, Germany). Finally, the adherent 
microorganisms were dislodged from the sample surfaces after ultrasonication for 1 min in 1 
ml 0.9 % NaCl on ice and several dilutions thereof were plated onto the CBA or HCB agar 
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plates for the determination of CFUs. This protocol was applied 3 times, obtaining an average 
of 9 independent measurements for each material group. 
Live /dead staining: The visualization of both live and dead adherent bacteria was aided by 
SYTO® 9 dye and propidium iodide (PI) (Live/Dead® BacLight™ Bacterial Viability Kit, 
Life Technologies GmbH, Darmstadt, Germany) as described in a previous report.[45] In short, 
the fluorescent dye was diluted to a concentration of 2 / 20 nmol ml−1 by adding in 0.9 % 
NaCl. Following incubation of the samples with salivary bacteria in a multi-well plate (12-
well plate; Greiner bio-one, Frickenhausen, Germany) at 37 °C for 2 h and 3 days (5 % CO2), 
respectively, 2 ml SYTO® 9 / PI in 0.9 % NaCl were inserted into each well. After the 2 h 
incubation, the samples were stabilized with superglue (Loctite 401, Loctite Deutschland 
GmbH, Munich, Germany) onto a slide and stored for 10 min in a dark chamber. 
Representative images were acquired for illustration of the vitality rates. After the 3 day 
incubation, the samples positioned face down onto a drop of 0.9 % NaCl chambered 
coverglass (µ Slide 8 well, ibidi GmbH, Munich, Germany) and monitored by confocal laser 
scanning microscopy (CLSM, Leica TCS SP2 AOBS, Mannheim, Germany) with a 63 × 
water immersion objective (HCX PL APO / bd. BL 63.0 × 1.2 W, Leica, Mannheim, 
Germany). The 3 day old biofilms were quantified by screening at three representative 
positions. The mean biofilm thickness was measured after establishing the upper and lower 
boundaries of the biofilms at these three points, which were then scanned in the Z-direction. 
As a result, 0.5 µm thick optical sections at 2 µm intervals were obtained throughout the 
biofilms. The 1.7 zoom setting corresponded to physical dimensions of 140 × 140 µm, and 
digital images of 1024 x 1024 pixels. Sequential scanning minimized the risk of spectral 
overlap. This assay was repeated twice, in duplicate. 
Statistical analysis: Data obtained by interferometry were analyzed using one-way ANOVA 
followed by Tukey’s post hoc test. The cell culture experiments were performed in triplicate 
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in three independent experiments (unless otherwise indicated). Differences between groups 
were examined for statistical significance using a one-way ANOVA followed by Tukey´s post 
hoc test for normally distributed data and a Kruskal-Wallis ANOVA followed by Dunn´s post 
hoc test for non-normally distributed data. For data obtained from the animal experiments a 
linear mixed model was fitted with random intercepts for each animal to evaluate time and 
surface effects on the response variable. Animals were considered as clusters since data are 
collected with several surfaces per animal. Furthermore, pairwise comparisons were 
performed. For statistical evaluation of the microbiological data a one-way ANOVA per 
response variable (aerobia, anaerobia) was applied to check for differences among the two 
different implants. A linear mixed model was fitted with random intercepts to evaluate 
material effects on response variables (live/dead), while pairwise comparisons between the 
two implant groups were conducted. The method of „Scheffe“ was applied to correct for the 
multiple testing problem (adjustment of p-values). The calculations were performed with the 
statistical software STATA 13 (StataCorp LP, College Station, USA). The significance level 
was set at 5%. 
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Figures 
 
Figure 1. Scanning electron micrographs of the implant test surfaces. SEM imaging 
parameters: EHT voltage level = 12.00 kV; magnification = 1000x and 4000x 
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Figure 2. A) Scanning electron micrographs (upper row) and actin cytoskeleton staining 
(lower row) of osteoblasts cultured for 24 h on 3Y-TZP, ZA8Sr8-Ce11 and titanium surfaces. 
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B) Quantitative morphometric analysis of osteoblast morphology on zirconia and titanium 
surfaces at days 1 and 7 (mean ± S.E.M; n = 142 - 547). C) Proliferation and metabolic 
activity of osteoblasts are represented by total DNA content in cell lysates and cellular 
reduction of the resazurin-based reporter dye alamarBlue (AB) at day 1, 3, 7 and 14 (mean ± 
S.E.M; n = 9). D) Azur II and Alizarin Red S (ARS) staining of osteoblasts cultured for 28 
days. Azur II (blue color) visualizes osteoblast monolayers under growth conditions, and ARS 
(red color) shows calcium deposition. *p < 0.05 significantly different from 3Y-TZP; #p<0.05 
significantly different from ZA8Sr8-Ce11; †p<0.05 significantly different from ZA8Sr8-Ce11p 
(Morphometry: Kruskal-Wallis ANOVA followed by Dunn´s post hoc test; Proliferation and 
AB: One Way ANOVA followed by Tukey´s post hoc test). SEM imaging parameters: EHT 
voltage level = 8.00 kV; magnification = 1000x and 4000x 
 
  
Figure 3. Histological specimens after 28 days of healing. The upper row shows the implants 
in the cortical bone area and the lower row the implants in the spongious bone area (scale bar: 
500 µm). The red color indicates mineralized bone (B) and blue color indicates soft tissue (S). 
It is evident that all groups showed mineralized bone-to-implant, as well as soft tissue-to-
implant contact. 
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Figure 4. (A, C) Initial bacterial adhesion of aerobic microorganisms after 2 hours and (B, D) 
biofilm formation after 3 days. 
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Table 1: For 3D surface evaluation by interferometry three disks and three miniature implants 
of each biomaterial surface were measured (mean values ± S.D.; n = 6 - 9). Surface 
parameters describing the topography of biomaterial surfaces were (i) Sa (arithmetic mean of 
the absolute surface asperity departures from the reference datum), (ii) Sq (root-mean-square 
value of asperity departures of a surface from the reference datum), (iii) Sdr (surface 
enlargement compared to a totally flat reference area) and (iv) Sds (density of summits, i.e. 
number of peaks per area). *p<0.05 significantly different from zirconia (3Y-TZP and 
ZA8Sr8-Ce11); #p<0.05 significantly different from 3Y-TZP and ZA8Sr8-Ce11 (One Way 
ANOVA followed by Tukey´s post hoc test).    
 Surface parameters 
 Average surface 
roughness (Sa) 
 [µm] ± S.D. 
Root mean square 
surface roughness 
(Sq) 
[µm] ± S.D. 
Developed area 
ratio (Sdr) 
[%] ± S.D. 
Summit density  
(Sds) 
[pks/mm²] 
± S.D. 
3Y-TZP 0.187 ± 0.021 0.243 ± 0.030 1.71 ± 0.09 95971 ± 4698 
ZA8Sr8-Ce11 0.211 ± 0.030 0.275 ± 0.035 1.70 ± 0.27 89643 ± 6278 
ZA8Sr8-Ce11p 0.228 ± 0.009 0.293 ± 0.019 3.18# ± 0.66 103723# ± 2526 
Ti 1.455* ± 0.072 1.865* ± 0.081 47.69* ± 1.46 64228* ± 1318 
     
Impl. 3Y-TZP 0.319 ± 0.013 0.390 ± 0.016 3.29 ± 0.06 147058 ± 2159 
Impl.ZA8Sr8-Ce11 0.343 ± 0.027 0.416 ± 0.037 3.00 ± 0.13 148142 ± 4774 
Impl.ZA8Sr8-Ce11p 0.773# ± 0.037 0.940# ± 0.043 43.00# ± 2.30 116347# ± 2075 
Imp.Ti 0.806# ± 0.083 1.090* ± 0.108 17.69* ± 2.40 82766* ± 2650 
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Table 2: Average bone-to-implant contact values of the examined surfaces in cortical and 
spongious bone areas at days 14 and 28 (mean values ± S.D.; n = 8 per group and healing 
period). The same superscript letter a, b, c indicates no significant difference between the 
groups (Linear mixed model followed by Scheffe´s post hoc test). 
 Cortical bone-implant contact  
[%] ± SD 
Spongious bone-implant contact  
[%] ± SD 
 14 days 28 days p = 14 days 28 days p = 
Impl. 3Y-TZP 28.1 ± 16.1a 55.3 ± 15.1b 0.0036 29.5 ± 13.7a 42.0 ± 17.8a,b 0.1386 
Impl.ZA8Sr8-Ce11 24.9 ± 11.2a 43.3 ± 16.9b 0.0219 20.3 ± 15.1a 47.8 ± 14.6b 0.0024 
Impl.ZA8Sr8-Ce11p 72.6 ± 16.9b 93.5 ± 7.2c 0.0061 46.2 ± 16.6b 81.1 ± 13.0c 0.0004 
Imp.Ti 10.7 ± 8.0a 16.9 ± 6.4a 0.1211 25.1 ± 9.5a 25.4 ± 11.8a 0.9612 
p < 0.0001 < 0.0001  = 0.0006 < 0.0001  
 
Table 3: Average push-in force to break the bone-to-implant contact at days 14 and 28 (mean 
values ± S.D.; n = 8 per group and healing period). The same superscript letter a, b indicates 
no significant difference between the groups in a column, i.e. between the different materials. 
The same superscript number 1, 2 indicates no significant difference between the different 
time points in a row, i.e. between 14 and 28 days of healing groups (Linear mixed model 
followed by Scheffe´s post hoc test). 
 Push-in force to break the bone-to-implant contact [N] ± S.D.  
 14 days 28 days p = 
Impl. 3Y-TZP 10.2 ± 6.6a,1 35.4 ± 20.7a,2 0.0055 
Impl.ZA8Sr8-Ce11 13.1 ± 11.3a,1 31.5 ± 22.8a,2 0.0348 
Impl.ZA8Sr8-Ce11p 63 ± 25.2b,1 65.5 ± 23.7b,1 0.8424 
Imp.Ti 23.9 ± 14.5b,1 9.9 ±9.0,1 0.360 
p < 0.0001 < 0.0001  
 




